Serum Biomarker Levels Improvement in Poly Cystic Ovarian Syndrome: Impact of Metformin Compared to Healthy Controls

NCT06479434 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

110

Enrollment

OTHER

Sponsor class

Conditions

Polycystic Ovary Syndrome
Insulin Resistance

Interventions

DRUG: Metformin

Sponsor

Aga Khan University

Collaborators

[object Object]